- Home
- SPRY vs ALEX Comparison
SPRY vs ALEX Comparison
Compare SPRY & ALEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- ALEX
- Stock Information
- Founded
- SPRY 2015
- ALEX 1870
- Country
- SPRY United States
- ALEX United States
- Employees
- SPRY N/A
- ALEX N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- ALEX Real Estate Investment Trusts
- Sector
- SPRY Health Care
- ALEX Real Estate
- Exchange
- SPRY Nasdaq
- ALEX Nasdaq
- Market Cap
- SPRY 1.1B
- ALEX 1.3B
- IPO Year
- SPRY N/A
- ALEX N/A
- Fundamental
- Price
- SPRY $12.57
- ALEX $17.54
- Analyst Decision
- SPRY Strong Buy
- ALEX Buy
- Analyst Count
- SPRY 4
- ALEX 3
- Target Price
- SPRY $26.00
- ALEX $22.50
- AVG Volume (30 Days)
- SPRY 1.5M
- ALEX 427.9K
- Earning Date
- SPRY 11-13-2024
- ALEX 02-26-2025
- Dividend Yield
- SPRY N/A
- ALEX 5.09%
- EPS Growth
- SPRY N/A
- ALEX N/A
- EPS
- SPRY N/A
- ALEX 0.61
- Revenue
- SPRY $2,568,000.00
- ALEX $230,949,000.00
- Revenue This Year
- SPRY $66,750.00
- ALEX N/A
- Revenue Next Year
- SPRY $508.63
- ALEX $2.08
- P/E Ratio
- SPRY N/A
- ALEX $21.40
- Revenue Growth
- SPRY 8460.00
- ALEX 1.30
- 52 Week Low
- SPRY $6.00
- ALEX $15.53
- 52 Week High
- SPRY $18.51
- ALEX $20.30
- Technical
- Relative Strength Index (RSI)
- SPRY 58.86
- ALEX 42.21
- Support Level
- SPRY $11.00
- ALEX $16.86
- Resistance Level
- SPRY $12.48
- ALEX $17.82
- Average True Range (ATR)
- SPRY 0.81
- ALEX 0.31
- MACD
- SPRY 0.28
- ALEX 0.07
- Stochastic Oscillator
- SPRY 84.95
- ALEX 70.10
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About ALEX Alexander & Baldwin Inc. REIT Holding Company
Alexander & Baldwin Inc operates in the real estate sector. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces and also urban ground leases in Hawaii, thereby accounting for majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.